AstraZeneca boosts heart, kidney business with $1.8B CinCor deal | HealthLeaders Media

Retrieved on: 2023-01-09 14:55:22

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca boosts heart, kidney business with $1.8B CinCor deal | HealthLeaders Media. View article details on hiswai:

Excerpt

(Reuters) - AstraZeneca said Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma Inc. for up to $1.8 billion to increase ...

Article found on: www.healthleadersmedia.com